Latest news articles

Added 3 months ago Drug news

FDA approves Slynd for contraception

Exeltis USA announced that the FDA has approved the new drug application (NDA) for Slynd (drospirenone 4 mg), an oral...

Added 4 months ago Drug news

Twirla is refiled with FDA as contraceptive patch

Agile Therapeutics has resubmitted to the FDA the NDA for its lead product candidate, Twirla, an investigational low-dose combined hormonal...

Added 4 months ago Drug news

Six-year data from phase III trial of Liletta shows cumulative pregnancy rates

Medicines360 presented new six-year data from the ongoing multi-center U.S.-based pivotal clinical trial investigating its intrauterine system (IUS), Liletta (levonorgestrel-releasing...

Search all news articles for Contraceptive and procreative management

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

EADV 2018 Highlights

EADV 2018 Highlights

EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Load more


Long-acting reversible contraception

This guideline covers long-acting reversible contraception. It aims to increase the use of long-action reversible contraception by improving the information given to women about their contraceptive choices.

Added 13 years ago

Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Clinical Practice Guideline for the diagnosis, staging, risk assessment, and treatment of different cancer types during pregnancy; obstetric care and fetal follow-up; pregnancy in cancer survivors; and fertility preservation...

Added 6 years ago

Search all guidelines for Contraceptive and procreative management

Journal articles

Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low dose combined oral contraceptive.

Objectives: Safe and effective contraceptive options for obese women are becoming more important due to the obesity epidemic within the...

Added 3 years ago

Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.

OBJECTIVE: To assess 3-year data on the efficacy and safety of a new 52-mg levonorgestrel intrauterine contraceptive (LNG20) designed for...

Added 4 years ago

The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy

Background: Oral contraception (OC) and postmenopausal hormone therapy (HT) can be used to alleviate menopausal symptoms. However, the risk of venous...

Added 6 years ago

Search all journal articles for Contraceptive and procreative management